Refining General Principles of Antiepileptic Drug Treatments for Epilepsy

키워드

참고문헌 (42)

1. Thijs RD, "Epilepsy in adults", Lancet, 393, pp.689~701 (2019)
2. Glauser T, "ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes", Epilepsia, 47, pp.1094~1120 (2006)
3. 이서영, "Estimating the Prevalence of Treated Epilepsy Using Administrative Health Data and Its Validity: ESSENCE Study", Journal of Clinical Neurology, 12(4), pp.434~440 (2016), 대한신경과학회[DOI]
4. Korean Epilepsy Society, "Clinical guideline for antiepileptic drug treatment in patient with epilepsy", Korean Epilepsy Society, ~ (2015)
5. Fisher RS, "ILAE official report : a practical clinical definition of epilepsy", Epilepsia, 55, pp.475~482 (2014)
6. French JA, "Clinical practice. Initial management of epilepsy", N Engl J Med, 359, pp.166~176 (2008)
7. Berg AT, "Risk of recurrence after a first unprovoked seizure", Epilepsia, 49(Suppl 1), pp.13~18 (2008)
8. "Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group)", Neurology, 43, pp.478~483 (1993)
9. Marson A, "Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures : a randomised controlled trial", Lancet, 365, pp.2007~2013 (2005)
10. Moshé SL, "Epilepsy : new advances", Lancet, 385, pp.884~898 (2015)
11. Bao EL, "Antiepileptic drug treatment after an unprovoked first seizure : a decision analysis", Neurology, 91, pp.e1429~e1439 (2018)
12. Lee SA, "Disclosure management behaviors in Korean adults with well-controlled epilepsy:their relation to perception of stigma", Epilepsy Behav, 67, pp.28~32 (2017)
13. Betjemann JP, "Status epilepticus in adults", Lancet Neurol, 14, pp.615~624 (2015)
14. Trinka E, "25 years of advances in the definition, classification and treatment of status epilepticus", Seizure, 44, pp.65~73 (2017)
15. Trinka E, "A definition and classification of status epilepticus--report of the ILAE Task Force on Classification of Status Epilepticus", Epilepsia, 56, pp.1515~1523 (2015)
16. Krumholz A, "Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society", Neurology, 84, pp.1705~1713 (2015)
17. Alldredge BK, "A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus", N Engl J Med, 345, pp.631~637 (2001)
18. Chamberlain JM, "Lorazepam vs diazepam for pediatric status epilepticus : a randomized clinical trial", JAMA, 311, pp.1652~1660 (2014)
19. Scheffer IE, "ILAE classification of the epilepsies : position paper of the ILAE Commission for Classification and Terminology", Epilepsia, 58, pp.512~521 (2017)
20. "Pharmaceutical integrated information system" (2019)[URL]
21. Leppik IE, "Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations", Epilepsia, 54, pp.28~35 (2013)
22. Anderson GD, "Modified-release formulations of secondgeneration antiepileptic drugs: pharmacokinetic and clinical aspects", CNS Drugs, 29, pp.669~681 (2015)
23. Lee SK, "Epilepsy in the elderly : treatment and consideration of co-morbid diseases", J Epilepsy Res, 9, pp.27~35 (2019)
24. Cramer JA, "Adverse effects of antiepileptic drugs : a brief overview of important issues", Expert Rev Neurother, 10, pp.885~891 (2010)
25. Perucca P, "Adverse effects of antiepileptic drugs", Lancet Neurol, 11, pp.792~802 (2012)
26. Biton V, "Effect of antiepileptic drugs on bodyweight : overview and clinical implications for the treatment of epilepsy", CNS Drugs, 17, pp.781~791 (2003)
27. Mintzer S, "Metabolic consequences of antiepileptic drugs", Curr Opin Neurol, 23, pp.164~169 (2010)
28. Man CB, "Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese", Epilepsia, 48, pp.1015~1018 (2007)
29. Chen P, "Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan", N Engl J Med, 364, pp.1126~1133 (2011)
30. McCormack M, "HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans", N Engl J Med, 364, pp.1134~1143 (2011)
31. Amstutz U, "Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions", Epilepsia, 55, pp.496~506 (2014)
32. Kwan P, "Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies", Epilepsia, 51, pp.1069~1077 (2010)
33. Brodie MJ, "Combining antiepileptic drugs--rational polytherapy?", Seizure, 20, pp.369~375 (2011)
34. French JA, "Rational polytherapy", Epilepsia, 50(Suppl 8), pp.63~68 (2009)
35. Lee BI, "Clinical opinion : earlier employment of polytherapy in sequential pharmacotherapy of epilepsy", Epilepsy Res, 156, pp.106165~ (2019)
36. Tang X, "Risk factors for seizure reoccurrence after withdrawal from antiepileptic drugs in individuals who have been seizure-free for over 2 years", PLoS One, 12, pp.e0181710~ (2017)
37. Lamberink HJ, "Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis", Lancet Neurol, 16, pp.523~531 (2017)
38. Ou S, "Long-term outcome of seizure-free patients and risk factors of relapse following antiepileptic drug withdrawal", Epilepsy Behav, 88, pp.295~300 (2018)
39. Schneider-von Podewils F, "Clinical predictors of the long-term social outcome and quality of life in juvenile myoclonic epilepsy : 20-65 years of follow-up", Epilepsia, 55, pp.322~330 (2014)
40. Skirrow C, "Long-term intellectual outcome after temporal lobe surgery in childhood", Neurology, 76, pp.1330~1337 (2011)
41. Chadwick D, "Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group", Epilepsia, 37, pp.1043~1050 (1996)
42. Braun KP, "Stopping antiepileptic drugs in seizure-free patients", Curr Opin Neurol, 27, pp.219~226 (2014)

관련 논문AI추천